BCDA Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
1.6M
-28.4%
2.3M
+12.6%
2.0M
+35.3%
1.5M
-27.5%
2.1M
R&D
893.0K
-27.7%
1.2M
+9.5%
1.1M
+20.5%
936.0K
-31.6%
1.4M
SG&A
730.0K
-29.2%
1.0M
+16.5%
885.0K
+60.3%
552.0K
-19.2%
683.0K
Operating Income
-1623000
+28.4%
-2266000
-12.6%
-2013000
-35.3%
-1488000
+27.5%
-2051000
EBITDA
-1620000
+28.4%
-2263000
-12.6%
-2010000
-35.4%
-1484000
+27.5%
-2046000
Net Income
-1613000
+28.6%
-2259000
-13.9%
-1984000
-33.8%
-1483000
+27.6%
-2049000
EPS (Basic)
$-0.13
+38.1%
$-0.21
-10.5%
$-0.19
+20.8%
$-0.24
+40.0%
$-0.40
EPS (Diluted)
$-0.13
+38.1%
$-0.21
-10.5%
$-0.19
+20.8%
$-0.24
+40.0%
$-0.40
Shares (Diluted)
12.1M
+11.8%
10.8M
+1.1%
10.7M
+70.4%
6.3M
+24.1%
5.1M
BioCardia (BCDA) โ€” Financials